Research map: Construction and validation of a predictive model for HBsAg loss in chronic hepatitis B patients treated with Peg-IFNα-2b

Back to the article

Papers in this map

  1. Requirements for global elimination of hepatitis B: a modelling study · Shevanthi Nayagam · 2016 · 387 citations · Cited by this paper
  2. Functional analyses of male-specific early-phosphorylated proteins reveal an intrinsically disordered protein required for microgamete release in Plasmodium berghei · 2026 · Related
  3. Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B · Jonggi Choi · 2018 · 290 citations · Cited by this paper
  4. Incremental diagnostic value of bloodstream pathogen ddPCR for early identification of blood culture-positive bloodstream infection · 2026 · Related
  5. HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleos(t)ide Analog: New Switch Study · Peng Hu · 2018 · 172 citations · Cited by this paper
  6. Cooperation of transposable elements to endow global networks of initiators of hybrid assembly pathways of endogenous multiprotein complexes · 2026 · Related
  7. Hepatitis B surface antigen seroclearance: Immune mechanisms, clinical impact, importance for drug development · Issam Tout · 2020 · 166 citations · Cited by this paper
  8. Longitudinal dynamics and treatment-associated determinants of interferon-gamma responses in tuberculosis: a 10-year retrospective QuantiFERON-TB Gold study · 2026 · Related
  9. Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial · Marc Bourlière · 2017 · 121 citations · Cited by this paper
  10. Diagnostic and differential diagnostic value of plasma extracellular vesicle-associated miRNAs in AIDS patients with tuberculosis and non-tuberculous mycobacterial infection · 2026 · Related
  11. Functional cure for chronic hepatitis B: accessibility, durability, and prognosis · Aixin Song · 2021 · 41 citations · Cited by this paper
  12. Lipid metabolism in the resuscitation of dormant mycobacterium tuberculosis: molecular resilience, host hijacking, and clinical opportunities · 2026 · Related
  13. Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B · Caixia Zheng · 2019 · 36 citations · Cited by this paper
  14. Admission CD4+ T cell BTLA expression and its association with infection risk and respiratory outcomes in sepsis · 2026 · Related
  15. Predictors of HBsAg seroclearance in patients with chronic HBV infection treated with pegylated interferon-α: a systematic review and meta-analysis · Shaowen Jiang · 2024 · 36 citations · Cited by this paper
  16. Prevalence and genetic diversity of respiratory syncytial viruses circulating in Bulgaria, 2023-2025 · 2026 · Related
  17. Clinical cure induced by pegylated interferon α-2b in the advantaged population of chronic hepatitis B virus infection: a retrospective cohort study · Chaojing Wen · 2024 · 20 citations · Cited by this paper
  18. Efficacy and safety of Omadacycline in community-acquired pneumonia among elderly patients: a real-world evidence study · 2026 · Related
  19. The role of Traditional Chinese medicine in anti-HBV: background, progress, and challenges · Feilin Ge · 2023 · 18 citations · Cited by this paper
  20. Association between indwelling urinary catheters and the poor prognosis among elderly patients with pulmonary infection · 2026 · Related
  21. Interferon add-on therapy increased clinical cure significantly for interferon-experienced chronic hepatitis B patients with low HBsAg · Xiaoàn Yang · 2022 · 16 citations · Cited by this paper
  22. Superiority of tenofovir alafenamide fumarate over entecavir for serum HBsAg level reduction in patients with chronic HBV infection: A 144-week outcome study after switching of the nucleos(t)ide analog · Yoshihito Uchida · 2022 · 15 citations · Cited by this paper
  23. Predictive model for HBsAg clearance rate in chronic hepatitis B patients treated with pegylated interferon α-2b for 48 weeks · Zhili Tan · 2024 · 9 citations · Cited by this paper
  24. Machine learning prediction of rapid HBsAg seroclearance at week 24 in inactive carriers treated with pegylated interferon · Jianxia Dong · 2025 · 8 citations · Cited by this paper
  25. Decrease in HBsAg After TAF Switching from Entecavir During Long-Term Treatment of Chronic Hepatitis B Virus Infection · Kazuto Tajiri · 2024 · 7 citations · Cited by this paper
  26. Exploring using HBsAg to predict interferon treatment course to achieve clinical cure in chronic hepatitis B patients: a clinical study · Fei Yan · 2025 · 7 citations · Cited by this paper
  27. Effect of interferon therapy on quality of life in patients with chronic hepatitis B · Mengdi Zhang · 2024 · 5 citations · Cited by this paper
  28. Determinants of functional cure in interferon-treated chronic hepatitis B: a retrospective cohort analysis of HBsAg dynamics and clinical predictors · Daqiong Zhou · 2025 · 4 citations · Cited by this paper
  29. A machine learning-based predictive model for 48-week hepatitis B surface antigen seroclearance in chronic hepatitis B patients treated with pegylated interferon α-2b: prediction at week 24 · Nan Kong · 2025 · 3 citations · Cited by this paper
  30. Evaluation of HBsAg and HBeAg seroconversion rates in patients diagnosed with chronic hepatitis B · Müge Toygar Deniz · 2025 · 2 citations · Cited by this paper
  31. Predictive value of hepatic, hematological, and immunological markers and their temporal dynamics in chronic hepatitis B functional cure · Jianyong Zeng · 2025 · 2 citations · Cited by this paper
  32. Retreatment hepatitis B surface antigen clearance prediction model identifies pegylated interferon alpha candidates in chronic hepatitis B · Yan-Chao Fu · 2025 · 2 citations · Cited by this paper
  33. Traditional Chinese Medicine Combined with Peginterferon α-2b in Chronic Hepatitis B: A Real-world Cohort Study · Huiqing Liang · 2025 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)